Company Cytek Biosciences, Inc.

Equities

CTKB

US23285D1090

Advanced Medical Equipment & Technology

Real-time Estimate Cboe BZX 08:33:44 07/05/2024 pm IST 5-day change 1st Jan Change
6.305 USD -1.79% Intraday chart for Cytek Biosciences, Inc. +4.41% -31.20%

Business Summary

Cytek Biosciences, Inc. is a cell analysis solutions company. The Company is advancing the cell analysis tools by delivering high-resolution, high-content and high-sensitivity cell analysis utilizing its Full Spectrum Profiling (FSP) technology. Its FSP platform includes its core instruments, the Cytek Aurora and Northern Lights systems; its cell sorter, the Cytek Aurora CS; the Cytek Orion reagent cocktail preparation system; the flow cytometer and imaging products under the Amnis and Guava brands; and reagents, software and services to provide a comprehensive and integrated suite of solutions for its customers. Its Cytek Aurora and Cytek Northern Lights systems are flow cytometers that deliver high-resolution, high-content, and high-sensitivity cell analysis. Its Cytek Aurora CS is a cell sorter that leverages the detection and sensitivity capabilities of its FSP technology to isolate living cell populations from lower to higher complexity panels beyond 40 biomarkers.

Number of employees: 676

Sales per Business

USD in Million2022Weight2023Weight Delta
Full Spectrum Flow Cytometry Platform
81.2 %
149 90.6 % 157 81.2 % +5.46%
Service
18.8 %
15 9.4 % 36 18.8 % +135.15%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
52.9 %
95 57.7 % 102 52.9 % +7.92%
EMEA
27.6 %
44 26.8 % 53 27.6 % +20.97%
APAC
16.4 %
23 13.7 % 32 16.4 % +40.29%
Other
3.2 %
3 1.8 % 6 3.2 % +107.69%

Managers

Managers TitleAgeSince
Founder 61 01/14/01
Founder 60 01/14/01
Chief Operating Officer 55 31/22/31
Investor Relations Contact - -
Sales & Marketing - 28/23/28
Human Resources Officer - -
Corporate Officer/Principal - 01/20/01
Corporate Officer/Principal 64 13/18/13
General Counsel 49 01/21/01
Corporate Officer/Principal 58 01/18/01

Members of the board

Members of the board TitleAgeSince
Director/Board Member 74 01/22/01
Director/Board Member 71 -
Director/Board Member 77 13/18/13
Corporate Officer/Principal 64 13/18/13
Founder 60 01/14/01
Director/Board Member 57 01/21/01
Founder 61 01/14/01
Director/Board Member 62 31/21/31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 131,264,277 119,888,200 ( 91.33 %) 0 91.33 %

Shareholders

NameEquities%Valuation
BlackRock Advisors LLC
12.94 %
16,933,768 12.94 % 114 M $
Brown Capital Management LLC
9.185 %
12,016,325 9.185 % 81 M $
Vanguard Fiduciary Trust Co.
9.089 %
11,890,700 9.089 % 80 M $
RA Capital Management LP
5.205 %
6,809,404 5.205 % 46 M $
HHLR Advisors Ltd. (Cayman Islands)
5.089 %
6,657,030 5.089 % 45 M $
Ming Yan
4.578 %
5,988,502 4.578 % 40 M $
5,303,911 4.054 % 36 M $
3,997,769 3.056 % 27 M $
New York State Common Retirement Fund
2.253 %
2,947,986 2.253 % 20 M $
Geode Capital Management LLC
1.878 %
2,456,535 1.878 % 16 M $

Company contact information

Cytek Biosciences, Inc.

47215 Lakeview Boulevard

94538, Fremont

+877 922 9835

http://www.cytekdev.com
address Cytek Biosciences, Inc.(CTKB)
  1. Stock Market
  2. Equities
  3. CTKB Stock
  4. Company Cytek Biosciences, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW